| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |